A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

NCT04277897 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: Hepenofovir Fumarate Tablets Single Dose
DRUG: Placebo
DRUG: Hepenofovir Fumarate Tablets Dose4

Sponsor

Xi'an Xintong Pharmaceutical Research Co.,Ltd.